Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page
- ChecktodayChange DetectedThe history now shows that the study is no longer seeking participants. The record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.SummaryDifference0.4%

- Check8 days agoChange DetectedA new revision (v3.5.5) was added to the record history, and the previous revision (v3.5.4) was removed. This update documents changes to the historical record of the study page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Record History shows the latest version updated to Revision: v3.5.4, replacing the previous v3.5.3.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s software/interface revision indicator updates from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site/version deployment rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check87 days agoChange DetectedNew revision added to the record history: v3.5.0 appears, indicating updates since the previous revision (v3.4.3).SummaryDifference0.1%

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.